Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 8, 2026, 7:47 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1153–1176 of 3,978 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Pathophysiology Clear all

Conditions: Cognitive Decline
Interventions: Souvenaid, Placebo; Drug · Other
Lead sponsor: University of Miami; Other
Eligibility: 55 Years to 89 Years
Enrollment: 67 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Postural Tachycardia Syndrome, Autonomic Dysfunction, Postural Orthostatic Tachycardia Syndrome, POTS - Postural Orthostatic Tachycardia Syndrome
Interventions: GammaCore intervention, STEPS management protocol; Device · Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 12 Years to 19 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024
U.S. locations: 2
States / cities: Rochester, Minnesota

Conditions: Ischemic Stroke, Intracerebral Hemorrhage, Subarachnoid Hemorrhage, Dementia, Vascular, Mild Cognitive Impairment, Vascular Cognitive Impairment
Interventions: Not listed
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 8,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2027
U.S. locations: 31
States / cities: Phoenix, Arizona • Los Angeles, California • San Diego, California + 24 more

Conditions: Proteinuria
Interventions: Belatacept; Drug
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2020
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Childhood Cancer, Survivorship, Sexual Dysfunction
Interventions: Interviews; Other
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 15 Years to 24 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 2
States / cities: Aurora, Colorado

Conditions: Mild Cognitive Impairment, Alzheimer's Disease
Interventions: Centella asiatica product, Placebo; Drug
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 60 Years to 85 Years
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Osteopathic Medicine, Breast Feeding
Interventions: Sham, Osteopathic Manipulation, OMT; Other
Lead sponsor: Methodist Medical Center of Illinois; Other
Eligibility: 20 Hours to 2 Weeks
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 2
States / cities: Peoria, Illinois

Conditions: Mild Cognitive Impairment, Cognitive Disorders
Interventions: 5-month aerobic exercise intervention; Behavioral
Lead sponsor: Wake Forest University; Other
Eligibility: 60 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Alzheimer's Disease, Mild Cognitive Impairment
Interventions: Nicotinamide, Placebo Comparator; Drug
Lead sponsor: University of California, Irvine; Other
Eligibility: 50 Years and older
Enrollment: 46 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2022
U.S. locations: 2
States / cities: Irvine, California • Los Angeles, California

Conditions: Fracture; Pelvic, Insufficiency Fractures, Fragility Fracture, Sacroiliac; Fusion, Sacroiliac Joint Disruption, Sacroiliac Joint Dysfunction
Interventions: iFuse TORQ TNT Implant System; Device
Lead sponsor: SI-BONE, Inc.; Industry
Eligibility: 60 Years and older
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 3
States / cities: Edina, Minnesota • Rochester, Minnesota • Wyomissing, Pennsylvania

Conditions: Prostate Adenocarcinoma, Incontinence Stress, Erectile Dysfunction Following Radical Prostatectomy
Interventions: Maximal urethral length preservation technique of robot assisted radical prostatectomy (RALP).; Procedure
Lead sponsor: Larkin Health System; Other
Eligibility: 18 Years and older · Male only
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Female Sexual Dysfunction
Interventions: Low dose testosterone nasal gel, single dose, Medium dose testosterone nasal gel, single dose, High dose testosterone nasal gel, single dose, Medium dose testosterone nasal gel, multiple dose; Drug
Lead sponsor: Acerus Pharmaceuticals Corporation; Industry
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Temporomandibular Joint Disorders, Bruxism, Temporomandibular Joint Dysfunction Syndrome, Myofascial Pain Dysfunction Syndrome, Temporomandibular Joint
Interventions: onabotulinumtoxinA; Drug
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years to 65 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Lung Transplant Failure and Rejection
Interventions: Not listed
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 501 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2024
U.S. locations: 4
States / cities: Los Angeles, California • Baltimore, Maryland • Durham, North Carolina + 1 more

Conditions: Cognitive Impairment Associated With Schizophrenia (CIAS)
Interventions: KYN-5356 low dose, Placebo, KYN-5356 Medium Dose, KYN-5356 High Dose; Drug · Other
Lead sponsor: Kynexis B.V.; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 149 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 15
States / cities: Little Rock, Arkansas • Cerritos, California • Lemon Grove, California + 12 more

Conditions: Heart Failure
Interventions: Blood Sample, Stool Sample; Other
Lead sponsor: University of Florida; Other
Eligibility: 18 Years and older
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2025
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Diabetes, Obese
Interventions: Exercise and muscle biopsies; Behavioral
Lead sponsor: Mayo Clinic; Other
Eligibility: 21 Years to 55 Years
Enrollment: 16 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Scottsdale, Arizona

Conditions: Menopausal and Perimenopausal Disorder, Unspecified, Atrophic Vaginitis
Interventions: Vaginal Lubrication Ring for Vaginal Dryness; Device
Lead sponsor: J3 Bioscience, Inc.; Industry
Eligibility: 35 Years and older · Female only
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Ciliary Dyskinesia, Primary, Kartagener Syndrome, Congenital Heart Defects, Situs Inversus
Interventions: Not listed
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 2 Years and older
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 2
States / cities: Washington D.C., District of Columbia • Bethesda, Maryland

Conditions: Coronary Microvascular Dysfunction
Interventions: Polyphenol-Rich Plant-Based Diet; Other
Lead sponsor: Emory University; Other
Eligibility: 45 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Cognitive Dysfunction, Lewy Body Disease, Synucleinopathies, Amyloid
Interventions: Donanemab, Placebo; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 55 Years to 85 Years
Enrollment: 350 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 42
States / cities: Chandler, Arizona • Scottsdale, Arizona • Carlsbad, California + 36 more

Conditions: Chronic Systolic Heart Failure (Dilated Cardiomyopathy)
Interventions: Not listed
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2007
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Hypertension, Pulmonary, Ventricular Dysfunction, Left
Interventions: Riociguat (Adempas, BAY63-2521), Placebo; Drug
Lead sponsor: Bayer; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 202 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2025
U.S. locations: 14
States / cities: Los Angeles, California • San Diego, California • Torrance, California + 11 more

Conditions: Somatic Dysfunction of Sacral Region, Somatic Dysfunction of Both Sacroiliac Joints, Somatic Dysfunction of Bilateral Lower Extremities
Interventions: Osteopathic Assessment; Other
Lead sponsor: The Touro College and University System; Other
Eligibility: 18 Years and older
Enrollment: 103 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: New York, New York

Search by objective public record fields.

Reducing the Effects of Aging on Cognition With Therapeutic Intervention of an Oral Nutrient (REACTION): A Pilot Trial

Non-invasive Vagal Neurostimulation (nVNS) in Adolescents With Postural Orthostatic Tachycardia Syndrome (POTS)

Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY

Belatacept Conversion in Proteinuric Kidney Transplant Recipients

Sexual Function Screening in Childhood Cancer Survivors

Safety and Target Engagement of Centella Asiatica in Cognitive Impairment

Osteopathic Manipulation in Breastfed Newborns

Mild Cognitive Impairment, Buddy Supported Exercise/ My Buddy Study

Nicotinamide as an Early Alzheimer's Disease Treatment

Real World Evidence of SI-BONE's iFuse TORQ TNT Advancing Treatment of Pelvic Ring Fractures

A Prospective Study to Evaluate the Impact of Maximal Urethral Length Preservation Technique During Robotic Laparoscopic Prostatectomy on the Stretched Flaccid Penile Length and Continence

PK Study of Testosterone Nasal Gel (TBS-2) in Healthy Premenopausal Women

Botox for Treatment of TMJ Disorder With Bruxism

Clinical Trials in Organ Transplantation Extension Study

A Study to Evaluate KYN-5356 in Adults With Cognitive Impairment Associated With Schizophrenia

The Role of Gut Microbiota in Heart Failure and Pre-Heart Failure With Preserved Ejection Fraction

Mitochondrial Dysfunction in Diabetes

Preliminary Study of a Vaginal Lubrication Ring to Treat the Symptoms of Vaginal Dryness

Dyskinesia, Heterotaxy and Congenital Heart Disease

A Plant-Based Diet in the Treatment of Coronary Microvascular Dysfunction

A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)

NORDIC: Nitric Oxide-Derived Oxidants and Regional Endothelial and Diastolic Dysfunction in Dilated Cardiomyopathy

A Study to Test the Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Left Ventricular Systolic Dysfunction

An Osteopathic Assessment of Lower Extremity Somatic Dysfunction in Runners